JPS61155327A - ジヒドロピリジン化合物を含有する抗動脈硬化剤 - Google Patents

ジヒドロピリジン化合物を含有する抗動脈硬化剤

Info

Publication number
JPS61155327A
JPS61155327A JP60277284A JP27728485A JPS61155327A JP S61155327 A JPS61155327 A JP S61155327A JP 60277284 A JP60277284 A JP 60277284A JP 27728485 A JP27728485 A JP 27728485A JP S61155327 A JPS61155327 A JP S61155327A
Authority
JP
Japan
Prior art keywords
compound
dihydropyridine
nitrophenyl
dihydropyridine compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60277284A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0529209B2 (enExample
Inventor
Isamu Yamaguchi
勇 山口
Jirou Hirokado
治郎 広角
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of JPS61155327A publication Critical patent/JPS61155327A/ja
Publication of JPH0529209B2 publication Critical patent/JPH0529209B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP60277284A 1984-12-10 1985-12-09 ジヒドロピリジン化合物を含有する抗動脈硬化剤 Granted JPS61155327A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848431119A GB8431119D0 (en) 1984-12-10 1984-12-10 Anti-arteriosclerotic composition
GB8431119 1984-12-10

Publications (2)

Publication Number Publication Date
JPS61155327A true JPS61155327A (ja) 1986-07-15
JPH0529209B2 JPH0529209B2 (enExample) 1993-04-28

Family

ID=10570949

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60277284A Granted JPS61155327A (ja) 1984-12-10 1985-12-09 ジヒドロピリジン化合物を含有する抗動脈硬化剤

Country Status (5)

Country Link
US (1) US4859688A (enExample)
EP (1) EP0185283B1 (enExample)
JP (1) JPS61155327A (enExample)
DE (1) DE3586420T2 (enExample)
GB (1) GB8431119D0 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782070A (en) * 1986-07-01 1988-11-01 Fujisawa Pharmaceutical Co., Ltd. Cerebral dysfunction therapeutic agent, which comprises a dihydropyridine compound
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
DE69016014T2 (de) * 1990-07-04 1995-08-31 Marcin Krotkiewski Blutdrucksenkendes Präparat.
IT1244728B (it) * 1991-02-13 1994-08-08 Glaxo Spa Impiego medicamentoso di derivati diidropiridinici
WO2004110354A2 (en) * 2003-05-15 2004-12-23 Roskamp Research, Llc Method for reducing amyloid deposition, amyloid neurotoxicity and microgliosis
CN101883564B (zh) * 2007-10-05 2013-10-16 阿尔茨海默病学会美国公司 使用(-)-尼伐地平对映体减少淀粉状蛋白沉积、淀粉状蛋白神经毒性和小神经胶质增生的方法
US20100093810A1 (en) * 2007-10-05 2010-04-15 Alzheimer's Institute Of America, Inc. Pharmaceutical Compositions for Reducing Amyloid Deposition, Amyloid Neurotoxicity, and Microgliosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338322A (en) * 1975-07-02 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
US4150119A (en) * 1976-10-22 1979-04-17 Jesus Emilio Lince Isaza Method for treatment of vascular disease
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
US4442100A (en) * 1979-12-11 1984-04-10 Bayer Aktiengesellschaft Substituted 2-amino-3,4-dihydropyridine derivatives, their production and their medicinal use
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
EP0125803A3 (en) * 1983-04-27 1987-01-21 FISONS plc Pharmaceutically active dihydropyridines

Also Published As

Publication number Publication date
EP0185283B1 (en) 1992-07-29
EP0185283A3 (en) 1989-07-19
EP0185283A2 (en) 1986-06-25
DE3586420D1 (de) 1992-09-03
US4859688A (en) 1989-08-22
JPH0529209B2 (enExample) 1993-04-28
DE3586420T2 (de) 1993-01-07
GB8431119D0 (en) 1985-01-16

Similar Documents

Publication Publication Date Title
EP0498069B1 (en) New use of peptide derivative
HU199302B (en) Process for producing synergic pharmaceutical compositions having hypotensive activity
JP2002537258A5 (enExample)
HU194053B (en) Process for preparing pharmaceutical compositions containing a combination of dihidro-pyridines and ace-inhibitors
US5026716A (en) Method of treatment of anxiety and anxio-depressive disorders
JPS63264421A (ja) 高脂質血症治療剤
CN102869360B (zh) 治疗高血压的医药组合物及方法
JPH04210924A (ja) カルシトニンの経口投与用の製薬組成物及び投薬形態
EP0185283B1 (en) Use of dihydropyridines for the treatment and prevention of arteriosclerosis
JPS62132826A (ja) 抗高血圧剤
JPS6056920A (ja) 脂質レベルの低減方法
AU621067B2 (en) A cardioprotective agent and a therapeutic agent for ischemic disease comprising N-containing heterocyclic compounds, and a process for the preparation of the same compounds
US5527801A (en) Ameliorant for blood lipid metabolism
JPWO1993005778A1 (ja) 血中脂質代謝改善剤
US5455257A (en) Lacidipine for the treatment of arteriosclerosis
IT8448082A1 (it) Composto farmaceutico a base d diidroergotossina per il trattamento dell'ipertensione
KR930004646B1 (ko) 심기능 부전의 예방 및 치료제
CA1337972C (en) Agent for treating hyperuricemia
US4225605A (en) Ergolene or ergoline compounds for treating congestive heart failure
JPH0647540B2 (ja) 虚血性心疾患・不整脈治療・予防剤
US20060074091A1 (en) Nootropic effect enhancer
JPS62161758A (ja) ジヒドロピリジン誘導体、その製法、これを含有する動脈血管収縮抑制剤及び脳内カルシウムイオン蓄積妨止剤
CA2058287A1 (en) Use of the (+) enantiomer of anipamil
WO1996025932A1 (en) Preventive/remedy for interstitial pneumonia, inflammatory intestinal diseases or vascular thickening containing quinolizinone compounds, salt thereof or hydrates therefor
ITRM940625A1 (it) Uso di esteri ftalidilidenici della carnitina e di alcanoil carnitine per il trattamento dello shock endotossico

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19931012